The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
Molecular Repolarisation of Tumour-Associated Macrophages
Open accessAbstract
The tumour microenvironment (TME) is composed of extracellular matrix and non-mutated cells supporting tumour growth and development. Tumour-associated macrophages (TAMs) are among the most abundant immune cells in the TME and are responsible for the onset of a smouldering inflammation. TAMs play a pivotal role in oncogenic processes as tumour proliferation, angiogenesis and metastasis, and they provide a barrier against the cytotoxic effector function of T lymphocytes and natural killer (NK) cells. However, TAMs are highly plastic cells that can adopt either pro- or anti-inflammatory roles in response to environmental cues. Consequently, TAMs represent an attractive target to recalibrate immune responses in the TME. Initial TAM-targeted strategies, such as macrophage depletion or disruption of TAM recruitment, have shown beneficial effects in preclinical models and clinical trials. Alternatively, reprogramming TAMs towards a proinflammatory and tumouricidal phenotype has become an attractive strategy in immunotherapy. This work summarises the molecular wheelwork of macrophage biology and presents an overview of molecular strategies to repolarise TAMs in immunotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Chatterjee, S., Mookerjee, A., Basu, J. M., Chakraborty, P., Ganguly, A., Adhikary, A., Mukhopadhyay, D., Ganguli, S., Banerjee, R., Ashraf, M., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007048 · Cited by 46
RetractedExploring the full spectrum of macrophage activation
Mosser, D. M., & Edwards, J. P. (2008) · Nature Reviews Immunology · doi:10.1038/nri2448 · Cited by 9,144 · cited 4×
“They support angiogenesis by secretion of adrenomedullin and vascular epithelial growth factors (VEGFs), and express immunosuppressive molecules such as IL10, programmed death ligand 1 (PD-L1) and transforming growth factor beta (TGFβ) [12,13].”
BackgroundInfluentialMacrophage Diversity Enhances Tumor Progression and Metastasis
Qian, B.-Z., & Pollard, J. W. (2010) · Cell · doi:10.1016/j.cell.2010.03.014 · Cited by 5,188
Tumor-Associated Macrophages: From Mechanisms to Therapy
Noy, R., & Pollard, J. W. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.010 · Cited by 4,089
Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm
Biswas, S. K., & Mantovani, A. (2010) · Nature Immunology · doi:10.1038/ni.1937 · Cited by 3,840
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis
Qian, B.-Z., Li, J., Zhang, H., Kitamura, T., Zhang, J., Campion, L. R., Kaiser, E. A., Snyder, L. A., & Pollard, J. W. (2011) · Nature · doi:10.1038/nature10138 · Cited by 2,874
CSF-1R inhibition alters macrophage polarization and blocks glioma progression
Pyonteck, S. M., Akkari, L., Schuhmacher, A. J., Bowman, R. L., Sevenich, L., Quail, D. F., Olson, O. C., Quick, M. L., Huse, J. T., Teijeiro, V., et al. (2013) · Nature Medicine · doi:10.1038/nm.3337 · Cited by 2,463
Molecular Mechanisms That Influence the Macrophage M1–M2 Polarization Balance
Wang, N., Liang, H., & Zen, K. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00614 · Cited by 1,980
The role of myeloid cells in the promotion of tumour angiogenesis
Murdoch, C., Muthana, M., Coffelt, S. B., & Lewis, C. E. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2444 · Cited by 1,642
Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Mantovani, A., & Sica, A. (2010) · Current Opinion in Immunology · doi:10.1016/j.coi.2010.01.009 · Cited by 1,484
Zhu, Y., Knolhoff, B. L., Meyer, M. A., Nywening, T. M., West, B. L., Luo, J., Wang-Gillam, A., Goedegebuure, S. P., Linehan, D. C., & DeNardo, D. G. (2014) · Cancer Research · doi:10.1158/0008-5472.can-13-3723 · Cited by 1,324
De Palma, M., Venneri, M. A., Galli, R., Sergi, L. S., Politi, L. S., Sampaolesi, M., & Naldini, L. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.002 · Cited by 1,311
Colony-stimulating factors in inflammation and autoimmunity
Hamilton, J. A. (2008) · Nature reviews. Immunology · doi:10.1038/nri2356 · Cited by 1,305
Tili, E., Michaille, J.-J., Cimino, A., Costinean, S., Dumitru, C. D., Adair, B., Fabbri, M., Alder, H., Liu, C. G., Calin, G. A., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5082 · Cited by 1,304
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Wyckoff, J., Wang, W., Lin, E. Y., Wang, Y., Pixley, F., Stanley, E. R., Graf, T., Pollard, J. W., Segall, J., & Condeelis, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1449 · Cited by 1,188
Trophic macrophages in development and disease
Pollard, J. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2528 · Cited by 1,178
Huang, Y., Yuan, J., Righi, E., Kamoun, W. S., Ancukiewicz, M., Nezivar, J., Santosuosso, M., Martin, J. D., Martin, M. R., Vianello, F., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1215397109 · Cited by 1,099
Rodell, C. B., Arlauckas, S. P., Cuccarese, M. F., Garris, C. S., Li, R., Ahmed, M. S., Kohler, R. H., Pittet, M. J., & Weissleder, R. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-018-0236-8 · Cited by 1,099
Macrophages Regulate the Angiogenic Switch in a Mouse Model of Breast Cancer
Lin, E. Y., Li, J.-F., Gnatovskiy, L., Deng, Y., Zhu, L., Grzesik, D. A., Qian, H., Xue, X.-N., & Pollard, J. W. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1278 · Cited by 1,074
Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors
Wyckoff, J. B., Wang, Y., Lin, E. Y., Li, J.-F., Goswami, S., Stanley, E. R., Segall, J. E., Pollard, J. W., & Condeelis, J. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1823 · Cited by 1,053
Immunotherapeutic uses of CpG oligodeoxynucleotides
Klinman, D. M. (2004) · Nature Reviews Immunology · doi:10.1038/nri1329 · Cited by 1,012
“Re-educating” tumor-associated macrophages by targeting NF-κB
Hagemann, T., Lawrence, T., McNeish, I., Charles, K. A., Kulbe, H., Thompson, R. G., Robinson, S. C., & Balkwill, F. R. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080108 · Cited by 792
Gocheva, V., Wang, H.-W., Gadea, B. B., Shree, T., Hunter, K. E., Garfall, A. L., Berman, T., & Joyce, J. A. (2010) · Genes & Development · doi:10.1101/gad.1874010 · Cited by 740
Goswami, S., Sahai, E., Wyckoff, J. B., Cammer, M., Cox, D., Pixley, F. J., Stanley, E. R., Segall, J. E., & Condeelis, J. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1853 · Cited by 738
Birge, R. B., Boeltz, S., Kumar, S., Carlson, J., Wanderley, J., Calianese, D., Barcinski, M., Brekken, R. A., Huang, X., Hutchins, J. T., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.11 · Cited by 725
Giraudo, E., Inoue, M., & Hanahan, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200422087 · Cited by 700
Rolny, C., Mazzone, M., Tugues, S., Laoui, D., Johansson, I., Coulon, C., Squadrito, M. L., Segura, I., Li, X., Knevels, E., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2010.11.009 · Cited by 695 · cited 2×
“Treatment with doxorubicin was potentiated by HRG overexpression, most likely due to the increased vessel perfusion [129].”
BackgroundQian, B., Deng, Y., Im, J. H., Muschel, R. J., Zou, Y., Li, J., Lang, R. A., & Pollard, J. W. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006562 · Cited by 664
Song, M., Liu, T., Shi, C., Zhang, X., & Chen, X. (2016) · ACS Nano · doi:10.1021/acsnano.5b06779 · Cited by 662
Much More than M1 and M2 Macrophages, There are also CD169+ and TCR+ Macrophages
Chávez-Galán, L., Olleros, M. L., Vesin, D., & Garcia, I. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00263 · Cited by 653
Porta, C., Rimoldi, M., Raes, G., Brys, L., Ghezzi, P., Di Liberto, D., Dieli, F., Ghisletti, S., Natoli, G., De Baetselier, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809784106 · Cited by 627
Georgoudaki, A.-M., Prokopec, K. E., Boura, V. F., Hellqvist, E., Sohn, S., Östling, J., Dahan, R., Harris, R. A., Rantalainen, M., Klevebring, D., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.04.084 · Cited by 609
High and low molecular weight hyaluronic acid differentially influence macrophage activation
Rayahin, J. E., Buhrman, J. S., Zhang, Y., Koh, T. J., & Gemeinhart, R. A. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00181 · Cited by 605
Distinct roles for cysteine cathepsin genes in multistage tumorigenesis
Gocheva, V., Zeng, W., Ke, D., Klimstra, D., Reinheckel, T., Peters, C., Hanahan, D., & Joyce, J. A. (2006) · Genes & Development · doi:10.1101/gad.1407406 · Cited by 570
Guiducci, C., Vicari, A. P., Sangaletti, S., Trinchieri, G., & Colombo, M. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-4262 · Cited by 549
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice
Meira, L. B., Bugni, J. M., Green, S. L., Lee, C.-W., Pang, B., Borenshtein, D., Rickman, B. H., Rogers, A. B., Moroski-Erkul, C. A., McFaline, J. L., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35073 · Cited by 548
Chen, D., Xie, J., Fiskesund, R., Dong, W., Liang, X., Lv, J., Jin, X., Liu, J., Mo, S., Zhang, T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03225-9 · Cited by 489
Bruton Tyrosine Kinase–Dependent Immune Cell Cross-talk Drives Pancreas Cancer
Gunderson, A. J., Kaneda, M. M., Tsujikawa, T., Nguyen, A. V., Affara, N. I., Ruffell, B., Gorjestani, S., Liudahl, S. M., Truitt, M., Olson, P., et al. (2016) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0827 · Cited by 486
Tumor-associated macrophages: function, phenotype, and link to prognosis in human lung cancer.
Quatromoni, J. G., & Eruslanov, E. B. (2012) · Europe PMC (PubMed Central) · Cited by 453
Coniglio, S. J., Eugenin, E., Dobrenis, K., Stanley, E. R., West, B. L., Symons, M. H., & Segall, J. E. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00217 · Cited by 428
Genard, G., Lucas, S., & Michiels, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00828 · Cited by 419
M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis
Kubota, Y., Takubo, K., Shimizu, T., Ohno, H., Kishi, K., Shibuya, M., Saya, H., & Suda, T. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20081605 · Cited by 388
Kloepper, J., Riedemann, L., Amoozgar, Z., Seano, G., Susek, K., Yu, V., Dalvie, N., Amelung, R. L., Datta, M., Song, J. W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1525360113 · Cited by 357
Mantovani, A., Sica, A., Allavena, P., Garlanda, C., & Locati, M. (2009) · Human Immunology · doi:10.1016/j.humimm.2009.02.008 · Cited by 350
Gazzaniga, S., Bravo, A. I., Guglielmotti, A., van Rooijen, N., Maschi, F., Vecchi, A., Mantovani, A., Mordoh, J., & Wainstok, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700827 · Cited by 302
Ohri, C. M., Shikotra, A., Green, R. H., Waller, D. A., & Bradding, P. (2009) · European Respiratory Journal · doi:10.1183/09031936.00065708 · Cited by 296
Cathepsin S Controls Angiogenesis and Tumor Growth via Matrix-derived Angiogenic Factors
Wang, B., Sun, J., Kitamoto, S., Yang, M., Grubb, A., Chapman, H. A., Kalluri, R., & Shi, G.-P. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m509134200 · Cited by 290
Aharinejad, S., Paulus, P., Sioud, M., Hofmann, M., Zins, K., Schäfer, R., Stanley, E. R., & Abraham, D. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0961 · Cited by 281
Coscia, M., Quaglino, E., Iezzi, M., Curcio, C., Pantaleoni, F., Riganti, C., Holen, I., Mönkkönen, H., Boccadoro, M., Forni, G., et al. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00926.x · Cited by 275
Raggi, F., Pelassa, S., Pierobon, D., Penco, F., Gattorno, M., Novelli, F., Eva, A., Varesio, L., Giovarelli, M., & Bosco, M. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01097 · Cited by 275
Watkins, S. K., Egilmez, N. K., Suttles, J., & Stout, R. D. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1357 · Cited by 273
Wang, Y., Lin, Y.-X., Qiao, S.-L., An, H.-W., Ma, Y., Qiao, Z.-Y., Rajapaksha, R. P. Y. J., & Wang, H. (2017) · Biomaterials · doi:10.1016/j.biomaterials.2016.09.034 · Cited by 266
Parayath, N. N., Parikh, A., & Amiji, M. M. (2018) · Nano Letters · doi:10.1021/acs.nanolett.8b00689 · Cited by 262
Chen, H.-M., van der Touw, W., Wang, Y. S., Kang, K., Mai, S., Zhang, J., Alsina-Beauchamp, D., Duty, J. A., Mungamuri, S. K., Zhang, B., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97570 · Cited by 253
Yan, D., Kowal, J., Akkari, L., Schuhmacher, A. J., Huse, J. T., West, B. L., & Joyce, J. A. (2017) · Oncogene · doi:10.1038/onc.2017.261 · Cited by 236
Paulus, P., Stanley, E. R., Schäfer, R., Abraham, D., & Aharinejad, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3523 · Cited by 231
Chen, P., Huang, Y., Bong, R., Ding, Y., Song, N., Wang, X., Song, X., & Luo, Y. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1354 · Cited by 227
Pockros, P. J., Guyader, D., Patton, H., Tong, M. J., Wright, T., McHutchison, J. G., & Meng, T.-C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.025 · Cited by 218
Improved Quenched Fluorescent Probe for Imaging of Cysteine Cathepsin Activity
Verdoes, M., Oresic Bender, K., Segal, E., van der Linden, W. A., Syed, S., Withana, N. P., Sanman, L. E., & Bogyo, M. (2013) · Journal of the American Chemical Society · doi:10.1021/ja4056068 · Cited by 212
Self-citationSu, M.-J., Aldawsari, H., & Amiji, M. (2016) · Scientific Reports · doi:10.1038/srep30110 · Cited by 194
Yan, D., Wang, H.-W., Bowman, R. L., & Joyce, J. A. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.035 · Cited by 194
Downey, C. M., Aghaei, M., Schwendener, R. A., & Jirik, F. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099988 · Cited by 193
Nakanishi, Y., Nakatsuji, M., Seno, H., Ishizu, S., Akitake-Kawano, R., Kanda, K., Ueo, T., Komekado, H., Kawada, M., Minami, M., et al. (2011) · Carcinogenesis · doi:10.1093/carcin/bgr128 · Cited by 190
Metformin-treated cancer cells modulate macrophage polarization through AMPK-NF-κB signaling
Chiang, C.-F., Chao, T.-T., Su, Y.-F., Hsu, C.-C., Chien, C.-Y., Chiu, K.-C., Shiah, S.-G., Lee, C.-H., Liu, S.-Y., & Shieh, Y.-S. (2017) · Oncotarget · doi:10.18632/oncotarget.14982 · Cited by 188
Xue, N., Zhou, Q., Ji, M., Jin, J., Lai, F., Chen, J., Zhang, M., Jia, J., Yang, H., Zhang, J., et al. (2017) · Scientific Reports · doi:10.1038/srep39011 · Cited by 181
Na, Y.-R., Yoon, Y.-N., Son, D.-I., & Seok, S.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063451 · Cited by 172
Ao, J.-Y., Zhu, X.-D., Chai, Z.-T., Cai, H., Zhang, Y.-Y., Zhang, K.-Z., Kong, L.-Q., Zhang, N., Ye, B.-G., Ma, D.-N., et al. (2017) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-16-0866 · Cited by 171
Sprinzl, M. F., Reisinger, F., Puschnik, A., Ringelhan, M., Ackermann, K., Hartmann, D., Schiemann, M., Weinmann, A., Galle, P. R., Schuchmann, M., et al. (2013) · Hepatology · doi:10.1002/hep.26328 · Cited by 169
Eubank, T. D., Roberts, R. D., Khan, M., Curry, J. M., Nuovo, G. J., Kuppusamy, P., & Marsh, C. B. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-1405 · Cited by 166
Vidyarthi, A., Khan, N., Agnihotri, T., Negi, S., Das, D. K., Aqdas, M., Chatterjee, D., Colegio, O. R., Tewari, M. K., & Agrewala, J. N. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01650 · Cited by 166
Ding, L., Liang, G., Yao, Z., Zhang, J., Liu, R., Chen, H., Zhou, Y., Wu, H., Yang, B., & He, Q. (2015) · Oncotarget · doi:10.18632/oncotarget.5541 · Cited by 165
Liu, M., Luo, F., Ding, C., Albeituni, S., Hu, X., Ma, Y., Cai, Y., McNally, L., Sanders, M. A., Jain, D., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501158 · Cited by 165
Tan, H.-Y., Wang, N., Man, K., Tsao, S., Che, C., & Feng, Y. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.271 · Cited by 162
Zhan, X., Jia, L., Niu, Y., Qi, H., Chen, X., Zhang, Q., Zhang, J., Wang, Y., Dong, L., & Wang, C. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.09.007 · Cited by 161
Cysteine cathepsins (proteases)—On the main stage of cancer?
Turk, V., Kos, J., & Turk, B. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00117-5 · Cited by 161
Zhang, X., Tian, W., Cai, X., Wang, X., Dang, W., Tang, H., Cao, H., Wang, L., & Chen, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065896 · Cited by 158
Yin, Y., Huang, X., Lynn, K. D., & Thorpe, P. E. (2013) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-13-0073 · Cited by 151
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation
Zhang, J., & Chen, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m800524200 · Cited by 150
Differential Regulation of the Let-7 Family of MicroRNAs in CD4+ T Cells Alters IL-10 Expression
Swaminathan, S., Suzuki, K., Seddiki, N., Kaplan, W. H., Cowley, M. J., Hood, C. L., Clancy, J. L., Murray, D. D., Méndez, C., Gelgor, L., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101196 · Cited by 144
Buhtoiarov, I. N., Sondel, P. M., Wigginton, J. M., Buhtoiarova, T. N., Yanke, E. M., Mahvi, D. A., & Rakhmilevich, A. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2010.03357.x · Cited by 143
Molecular Pathways: Deciphering Mechanisms of Resistance to Macrophage-Targeted Therapies
Quail, D. F., & Joyce, J. A. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0133 · Cited by 142
Huang, Z. D., Yang, Y., Jiang, Y., Shao, J., Sun, X., Chen, J., Dong, L., & Zhang, J. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.09.062 · Cited by 135
Chow, L. Q. M., Morishima, C., Eaton, K. D., Baik, C. S., Goulart, B. H. L., Anderson, L. N., Manjarrez, K. L., Dietsch, G. N., Bryan, J. K., Hershberg, R. M., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1934 · Cited by 132
Lipid peroxidation dominates the chemistry of DNA adduct formation in a mouse model of inflammation
Pang, B., Zhou, X., Yu, H., Dong, M., Taghizadeh, K., Wishnok, J. S., Tannenbaum, S. R., & Dedon, P. C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm037 · Cited by 131
Peng, H., Chen, B., Huang, W., Tang, Y., Jiang, Y., Zhang, W., & Huang, Y. (2017) · Nano Letters · doi:10.1021/acs.nanolett.7b03756 · Cited by 116
Toll-like Receptor Agonist Conjugation: A Chemical Perspective
Ignacio, B. J., Albin, T. J., Esser-Kahn, A. P., & Verdoes, M. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00808 · Cited by 114
Self-citationExtratumoral Macrophages Promote Tumor and Vascular Growth in an Orthotopic Rat Prostate Tumor Model
Bergström, S. H., Rudolfsson, S. H., van Rooijen, N., & Bergh, A. R. J. (2009) · Neoplasia · doi:10.1593/neo.81338 · Cited by 112
A phase I clinical trial of imiquimod, an oral interferon inducer, administered daily
Savage, P. M., Horton, V. L., Moore, J. L., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.569 · Cited by 109
Chen, N., Wei, M., Sun, Y., Li, F., Pei, H., Li, X., Su, S., He, Y., Wang, L., Shi, J., et al. (2013) · Small · doi:10.1002/smll.201300903 · Cited by 107
Laoui, D., Overmeire, E. V., Movahedi, K., den Bossche, J. V., Schouppe, E., Mommer, C., Nikolaou, A., Morias, Y., BAETSELIER, P. D., & Ginderachter, J. A. V. (2011) · Immunobiology · doi:10.1016/j.imbio.2011.06.007 · Cited by 105
Jia, X., Yu, F., Wang, J., Iwanowycz, S., Saaoud, F., Wang, Y., Hu, J., Wang, Q., & Fan, D. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3164-7 · Cited by 104
Liu, Q., Tong, D., Liu, G., Gao, J., Wang, L.-A., Xu, J., Yang, X., Xie, Q., Huang, Y., Pang, J., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0420 · Cited by 104
Huang, Z. D., Gan, J., Long, Z., Guo, G., Shi, X., Wang, C., Zang, Y., Ding, Z., Chen, J., Zhang, J., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.03.009 · Cited by 99
Li, Y., Wang, F., Wang, L., Huang, L. J., Wang, J., Zhang, B., & Zhang, Y. (2015) · Oncotarget · doi:10.18632/oncotarget.3547 · Cited by 95
Monk, B. J., Brady, M. F., Aghajanian, C. A., Lankes, H. A., Rizack, T., Leach, J. W., Fowler, J. M., Higgins, R. V., Hanjani, P., Morgan, M. A., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx049 · Cited by 94
Alsaab, H. O., Sau, S., Alzhrani, R. M., Cheriyan, V. T., Polin, L., Vaishampayan, U. N., Rishi, A. K., & Iyer, A. K. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.08.053 · Cited by 85
Evaluation of the potential therapeutic benefits of macrophage reprogramming in multiple myeloma
Gutiérrez‐González, A., Martínez‐Moreno, M., Samaniego, R., Arellano‐Sánchez, N., Salinas-Muñoz, L., Relloso, M., Valeri, A., Martínez‐López, J., Corbí, A. L., Hidalgo, A., et al. (2016) · Blood · doi:10.1182/blood-2016-01-695395 · Cited by 81
Qin, T., Wang, C., Chen, X., Duan, C., Zhang, X., Zhang, J., Chai, H., Tang, T., Chen, H., Yue, J., et al. (2015) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2015.03.021 · Cited by 76
Ortega, R. A., Barham, W. J., Sharman, K., Tikhomirov, O., Giorgio, T. D., & Yull, F. E. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s93483 · Cited by 76
Euodenine A: A Small-Molecule Agonist of Human TLR4
Neve, J. E., Wijesekera, H., Duffy, S., Jenkins, I. D., Ripper, J. A., Teague, S. J., Campitelli, M. R., Garavelas, A., Nikolakopoulos, G., Le, P. V., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401321v · Cited by 73
Modulation of Innate Immune Responses via Covalently Linked TLR Agonists
Tom, J. K., Dotsey, E. Y., Wong, H. Y., Stutts, L., Moore, T., Davies, D. H., Felgner, P. L., & Esser-Kahn, A. P. (2015) · ACS Central Science · doi:10.1021/acscentsci.5b00274 · Cited by 69
TREM-1 regulates macrophage polarization in ureteral obstruction
Lo, T.-H., Tseng, K.-Y., Tsao, W.-S., Yang, C.-Y., Hsieh, S.-L. E., Chiu, A. W.-H., Takai, T., Mak, T. W., Tarng, D., & Chen, N. (2014) · Kidney International · doi:10.1038/ki.2014.205 · Cited by 68
Jeong, S. K., Yang, K., Park, Y. S., Choi, Y. J., Oh, S. J., Lee, C. W., Lee, K. Y., Jeong, M. H., & Jo, W. S. (2014) · International Immunopharmacology · doi:10.1016/j.intimp.2014.07.004 · Cited by 64
Comito, G., Segura, C. P., Taddei, M. L., Lanciotti, M., Serni, S., Morandi, A., Chiarugi, P., & Giannoni, E. (2016) · Oncotarget · doi:10.18632/oncotarget.9497 · Cited by 64
Zhang, L. J., Dewan, V., & Yin, H. H. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00419 · Cited by 62
Gao, J., Wang, D., Liu, D., Liu, M., Ge, Y., Jiang, M., Liu, Y., & Zheng, D. (2015) · Molecular Biology of the Cell · doi:10.1091/mbc.e15-04-0209 · Cited by 60
Cardoso, A. P., Gonçalves, R. M., Antunes, J. C., Pinto, M. L., Pinto, A. T., Castro, F., Monteiro, C. F., Barbosa, M. A., & Oliveira, M. J. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.05.022 · Cited by 56
Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides
Shinchi, H., Crain, B., Yao, S., Chan, M., Zhang, S. S., Ahmadiiveli, A., Suda, Y., Hayashi, T., Cottam, H. B., & Carson, D. A. (2015) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.5b00285 · Cited by 48
Zhang, Y., Ishida, C. T., Ishida, W., Lo, S.-F. L., Zhao, J., Shu, C., Bianchetti, E., Kleiner, G., Sanchez‐Quintero, M. J., Quinzii, C. M., et al. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-0260 · Cited by 47
Chalasani, P., Marron, M., Roe, D. J., Clarke, K., Iannone, M., Livingston, R. B., Shan, J. S., & Stopeck, A. (2015) · Cancer Medicine · doi:10.1002/cam4.447 · Cited by 45
Kim, D. H., Sung, B., Kim, J.-A., Kang, Y. J., Hwang, S. Y., Hwang, N. L., Suh, H., Choi, Y. H., Im, E., Chung, H. Y., et al. (2017) · International Journal of Oncology · doi:10.3892/ijo.2017.4058 · Cited by 43
Chakraborty, P., Chatterjee, S., Ganguly, A., Saha, P., Adhikary, A., Das, T., Chatterjee, M., & Choudhuri, S. K. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0611287 · Cited by 41
Jia, X.-H., Du, Y., Mao, D., Wang, Z., He, Z., Qiu, J., Ma, X., Shang, W., Ding, D., & Tian, J. (2015) · Oncotarget · doi:10.18632/oncotarget.4658 · Cited by 39
Zhang, Y., Cao, Y. Q., Sun, X., Feng, Y., Du, Y., Liu, F., Yu, C., & Jin, F. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.11.027 · Cited by 39
Consistent Inhibition of Cyclooxygenase Drives Macrophages towards the Inflammatory Phenotype
Na, Y. R., Yoon, Y. N., Son, D., Jung, D., Gu, G., & Seok, S. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118203 · Cited by 37
Goff, P. H., Hayashi, T., He, W., Yao, S., Cottam, H. B., Tan, G. S., Crain, B., Krammer, F., Messer, K. S., Pu, M., et al. (2017) · Journal of Virology · doi:10.1128/jvi.01050-17 · Cited by 37
CDDO-Me Redirects Activation of Breast Tumor Associated Macrophages
Ball, M. S., Shipman, E. P., Kim, H. J., Liby, K. T., & Pioli, P. A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0149600 · Cited by 34
Han, L., Wang, T., Wu, J., Yin, X., Fang, H., & Zhang, N. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s118727 · Cited by 32
Banerjee, S., Halder, K., Ghosh, S., Bose, A., & Majumdar, S. (2015) · OncoImmunology · doi:10.1080/2162402x.2014.995559 · Cited by 31
Wang, C., Hu, Z., Zhu, Z., Zhang, X., Wei, Z., Zhang, Y., Hu, D., & Cai, Q. (2015) · Tumor Biology · doi:10.1007/s13277-015-4451-6 · Cited by 27
Booth, L. A., Roberts, J. L., Poklepovic, A. S., & Dent, P. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1507258 · Cited by 27
Yu, N., Fu, S., Xu, Z., Liu, Y., Hao, J., Zhang, A., & Wang, B. (2015) · International Journal of Cancer · doi:10.1002/ijc.29713 · Cited by 25
CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma
Gao, X., Deeb, D., Liu, Y., Liu, P., Zhang, Y., Shaw, J., & Gautam, S. C. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3212 · Cited by 20
Seif, M., Hoppstädter, J., Breinig, F., & Kiemer, A. K. (2017) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2017.03.008 · Cited by 20
Efficacy of gefitinib‑celecoxib combination therapy in docetaxel‑resistant prostate cancer
Lin, J., Hameed, I., Xu, Z., Yu, Y., Ren, Z., & Zhu, J. (2018) · Oncology Reports · doi:10.3892/or.2018.6595 · Cited by 13
Zhao, X., Pan, S.-Y., Huang, Q., Lu, Y.-N., Wu, X., Chang, J., Liu, Z., Cai, X., Liu, Q., Wang, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9891 · Cited by 12
Dahal, L. N., Gadd, A., Edwards, A. D., Cragg, M. S., & Beers, S. A. (2018) · Scandinavian Journal of Immunology · doi:10.1111/sji.12666 · Cited by 6
Cited by
Macrophage-Based Approaches for Cancer Immunotherapy
Anderson, N. R., Minutolo, N. G., Gill, S., & Klichinsky, M. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2990 · Cited by 698
Jayasingam, S. D., Citartan, M., Thang, T. H., Mat Zin, A. A., Ang, K. C., & Ch'ng, E. S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2019.01512 · Cited by 635
M1/M2 macrophages and their overlaps – myth or reality?
Strizova, Z., Benesova, I., Bartolini, R., Novysedlak, R., Cecrdlova, E., Foley, L. K., & Striz, I. (2023) · Clinical Science · doi:10.1042/cs20220531 · Cited by 612
Immunotherapy: Reshape the Tumor Immune Microenvironment
LV, B., Wang, Y., Ma, D., Cheng, W., Liu, J., Yong, T., Chen, H., & Wang, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.844142 · Cited by 482
Responsive Exosome Nano-bioconjugates for Synergistic Cancer Therapy
Nie, W., Wu, G., Zhang, J., Huang, L., Ding, J., Jiang, A., Zhang, Y., Liu, Y., Li, J., Pu, K., et al. (2020) · Angewandte Chemie International Edition · doi:10.1002/anie.201912524 · Cited by 376
Metadata
- Authors
- Van Dalen, F. J., Van Stevendaal, M. H. M. E., Fennemann, F. L., Verdoes, M., & Ilina, O.
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2018-12-20
- Volume
- 24
- Issue
- 1
- Pages
- 9
- ISSN
- 1420-3049 (ISSN-L)
- OpenAlex
- W2904889333
- Cited by
- 302
- References
- 130
- FWCI
- 9.42
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.